Moderna’s COVID-19 vaccine indicates 94.1% efficacy against virus, 100% in severe cases

Moderna’s COVID-19 vaccine indicates 94.1% efficacy against virus, 100% in severe cases

Moderna’s coronavirus drug candidate was ‘generally well tolerated’ and had ‘no serious safety concerns’
Read More